Pemetrexed Injection Market

Pemetrexed is an antifolate agent with pyrrolidine pyrimidine group at its core. It can inhibit the growth of tumor by disrupting the normal folate dependent metabolic process in cells and inhibiting cell replication.
Pemetrexed Injection Market contains market size and forecasts of Pemetrexed Injection in global, including the following market information:
Global Pemetrexed Injection Market Revenue, 2018-2023, 2023-2030, ($ millions)
Global Pemetrexed Injection Market Sales, 2018-2023, 2023-2030, (K Units)
Global top five Pemetrexed Injection companies in 2022 (%)
The global Pemetrexed Injection market was valued at million in 2022 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period 2023-2030.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million by 2030.
0.5g Bottle Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Pemetrexed Injection include Eagle Pharmaceuticals, AuroMedics Pharma, Teva Pharmaceutical Industries, Taro Pharma, Seacross Pharmaceuticals, Simcere Pharmaceutical Group, Qilu Pharmaceutical, Pfizer and Jiangsu Anda Pharmaceutical, etc. In 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Pemetrexed Injection manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Pemetrexed Injection Market, by Type, 2018-2023, 2023-2030 ($ Millions) & (K Units)
Global Pemetrexed Injection Market Segment Percentages, by Type, 2022 (%)
0.5g Bottle
0.2g Bottle
Global Pemetrexed Injection Market, by Application, 2018-2023, 2023-2030 ($ Millions) & (K Units)
Global Pemetrexed Injection Market Segment Percentages, by Application, 2022 (%)
Non Squamous Non-Small Cell Lung Cancer
Squamous Cell Non-Small Cell Lung Cancer
Global Pemetrexed Injection Market, By Region and Country, 2018-2023, 2023-2030 ($ Millions) & (K Units)
Global Pemetrexed Injection Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Pemetrexed Injection revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Pemetrexed Injection revenues share in global market, 2022 (%)
Key companies Pemetrexed Injection sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Pemetrexed Injection sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Eagle Pharmaceuticals
AuroMedics Pharma
Teva Pharmaceutical Industries
Taro Pharma
Seacross Pharmaceuticals
Simcere Pharmaceutical Group
Qilu Pharmaceutical
Pfizer
Jiangsu Anda Pharmaceutical
Yangtze River Pharmaceutical Group
Hansoh Pharmaceutical Group Company?????
Nanjing Pharmaceutical Factory
DEYAO PHARMA
Vianex S.A.-Plant C
Hainan Jinrui Pharmaceutical